Your browser doesn't support javascript.
loading
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience.
Azizi, Armon; Ediriwickrema, Asiri; Dutta, Ritika; Patel, Shyam A; Shomali, William; Medeiros, Bruno; Iberri, David; Gotlib, Jason; Mannis, Gabriel; Greenberg, Peter; Majeti, Ravindra; Zhang, Tian.
Afiliación
  • Azizi A; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA.
  • Ediriwickrema A; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA.
  • Dutta R; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA.
  • Patel SA; Department of Medicine, Division of Hematology-Oncology, UMass Memorial Medical Center, University of Massachusetts Medical School, Worcester, MA, USA.
  • Shomali W; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA.
  • Medeiros B; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA.
  • Iberri D; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA.
  • Gotlib J; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA.
  • Mannis G; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA.
  • Greenberg P; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA.
  • Majeti R; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA.
  • Zhang T; Department of Medicine, Division of Hematology, Cancer Institute, Stanford University, Stanford, CA, USA.
Leuk Lymphoma ; 61(11): 2700-2707, 2020 11.
Article en En | MEDLINE | ID: mdl-32543932

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos